Robocath launches new robotic platform R-One+
Robocath, a company that designs, develops and commercialises smart robotic solutions for the treatment of cardiovascular diseases, has announced the launch of its latest robotic platform - the R-One+.
“The launch of R-One+ shows what our company is all about — that is, listening to our users’ needs and fostering exceptional partnerships between our different units in order to produce the best possible results for physicians. I would like to thank the medical community for giving their time so willingly and for their excellent advice. I would also like to thank all our staff who have worked so hard to launch this new robotic platform and, in doing so, taken us one step further on our roadmap to greater commercial success,” said Lucien Goffart, CEO of Robocath.
“Robotic technology is digitisating endovascular medicine. I’m delighted that we are now launching R-One+; this solution marks a major step forward in the digital transformation of the cathlab as we continue to work towards our goal of ensuring better care for patients and better protection for medical staff,” said Philippe Bencteux, president and founder of Robocath.
The R-One+ robotic solution allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room. This is designed to create two main benefits: firstly, the system protects the cardiologist and the medical team against radiation-induced injuries, and secondly it makes the PCI procedure easier and safer. Due to R-One+, cardiologists can perform enhanced hand gestures with even greater precision and in more comfortable working conditions.
“For the first time, I was able to perform several robotic angioplasties from the comfort of my chair in the control room, where I was completely shielded from X-rays and could dispense with my lead apron. I also benefited from the excellent visibility on the radioscopy and haemodynamic monitoring screens. This new set-up has changed the way we organise our procedures and has given nursing staff the opportunity to develop new skills. This new approach has also enabled doctors to shift their focus back to their core activities and to perform procedures in complete safety and with millimetre precision. I’m excited to incorporate this new robotic technology into my day-to-day work. Without doubt, it opens up some new and extremely promising avenues for the treatment of cardiovascular diseases, especially in the case of long and complex procedures,” said Dr. Mohammed Nejjari, interventional cardiologist at the Centre Cardiologique du Nord (CCN) in Saint-Denis, France.
“R-One+ makes it extremely easy to position devices with millimetre precision. It’s also much more comfortable to operate using robotic technology, and, as the principal operator, I am completely protected from radiation. I firmly believe that robotics has a major role to play in the transformation of interventional cardiology and the use of this technology will mark a new chapter in the history of our field,” said Prof. Michael Haude, interventional cardiologist at the Lukaskrankenhaus hospital in Neuss, Germany.